Efficacy and safety of sotagliflozin in treating diabetes type 1

2017 ◽  
Vol 19 (3) ◽  
pp. 307-315 ◽  
Author(s):  
Marc S. Rendell
2020 ◽  
Author(s):  
Dominik Sethe ◽  
Arndt Büssing ◽  
Dörte Hilgard ◽  
Bettina Berger

2000 ◽  
Vol 50 ◽  
pp. 115
Author(s):  
L. Calzada ◽  
C. Fuscaldo ◽  
E. Artavia ◽  
Y. Estrada ◽  
L. Jaramillo ◽  
...  

2021 ◽  
Vol 5 (7) ◽  
pp. 01-04
Author(s):  
Vida Tajiknia ◽  
Maryam Ghandali ◽  
Ardavan Ahmadvand ◽  
Ali Afrasiabi ◽  
Reza Pirdehghan ◽  
...  

Since the first month of this new pandemic situation, all around the world healthcare system has been facing different challenges and difficulties; patients with chronic diseases such as cancer or diabetes with impaired immune system were at greater risk of infections and complications. It goes without saying that this issue was extremely important among pediatric clinicians dealing with diabetic pediatrics. Diabetes is the number one chronic illness among pediatric patients and the most dangerous and frightened complication of it is Diabetic Ketoacidosis (DKA). Studies have shown a strong association between pandemic and increase in new diabetes type 1 cases and its lethal complication called DKA. Here we are going to take a look at existing data and report about cases with this condition trying to find the missing piece of a big puzzle; what is the role of Covid-19 in causing Diabetes in previously healthy kids and what is the real association between SARS-COV2 virus infection and DKA? We are going to review different studies, possible mechanism, new t1dm cases and old cases, with or without covid infection, DKA cases and its severity.


Sign in / Sign up

Export Citation Format

Share Document